HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Haeften, T. W. Articles by van Doorn, J. Search for Related Content PubMed PubMed Citation Articles by van Haeften, T. W. Articles by van Doorn, J. Social Bookmarking                What's this?

IGF-Binding Protein-1 Levels Are Related to Insulin-Mediated Glucose Disposal and Are a Potential Serum Marker of Insulin Resistance

Response to Maddux et al.

¹ Department of Internal Medicine, University Medical Center, Utrecht, the Netherlands
² Department of Medical Physiology, University Medical Center Utrecht, Utrecht, the Netherlands
³ Department of Rehabilitation Medicine, Academic Medical Center Amsterdam, Amsterdam, the Netherlands
⁴ Department of Metabolic and Endocrine Diseases, University Center Utrecht, Utrecht, the Netherlands

Address correspondence to Dr. T.W. van Haeften, Department of Internal Medicine F02.126, University Medical Center Utrecht, P.O. Box 85500, NL 3508 GA Utrecht, Netherlands. E-mail: t.w.vanhaeften{at}umcutrecht.nl

We were interested in the article of Maddux et al. (1) in which they found a correlation coefficient of 0.75 for the relationship of IGF-binding protein (IGFBP)-1 with insulin sensitivity. Often, the homeostasis model assessment of insulin resistance (HOMA-IR) or other assessments such as the Stumvoll Index (2) are used. Because hepatic production of IGFBP-1 is under direct inhibitory influence of insulin, plasma IGFBP-1 levels could potentially be of use for the assessment of insulin sensitivity. IGFBP-2 has also been associated with the metabolic syndrome and nutritional status. For 62 nondiabetic subjects who underwent a hyperinsulinemic-euglycemic clamp (3), we determined plasma IGFBP-1 and IGFBP-2 levels through established radioimmunoassays (4). We found a linear correlation of insulin sensitivity (clamp; µm · kg lean body mass^–1 · min^–1 per pmol/l) with HOMA-IR (r = 0.573, P < 0.0005). As expected, plasma IGFBP-1 inversely correlated with fasting plasma insulin levels and HOMA-IR (r = –0.448 and –0.446, respectively; both P < 0.0005), but the correlation of plasma IGFBP-1 with insulin sensitivity (clamp) had an appreciably lower correlation coefficient (r = 0.228, P = 0.074). Similarly, plasma IGFBP-2 correlated with plasma insulin levels and HOMA-IR (r = –0.271, P = 0.027 and r = –0.262, P = 0.032, respectively) but not with insulin sensitivity (r = 0.141, P = 0.28).To study whether plasma IGFBP-1 levels could be of further use in assessing insulin sensitivity from basal values, we assessed the relationship of insulin sensitivity with age, BMI, waist circumference, fasting plasma insulin, and fasting plasma glucose with multiple linear correlation with and without the inclusion of IGFBP-1. Inclusion of IGFBP-1 did not improve the regression (nor did IGFBP-2, waist circumference, or fasting plasma glucose): insulin sensitivity = 0.141 – 0.0005 x age – 0.00185 x BMI – 0.000773 x fasting insulin (overall R = 0.646, P < 0.0005; insulin in pmol/l).

We conclude that plasma IGFBP-1 has only a very modest relation with insulin sensitivity; in our experience, plasma IGFBP-1 (or IGFBP-2) does not improve the assessment of an index for insulin sensitivity as performed with our modification of the Stumvoll Index (2).

References

1. Maddux BA, Chan A, Mandarino LJ, Goldfine ID, DeFilippis EA: IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance. Diabetes Care 29:1535–1537, 2006[Abstract/Free Full Text]
   
2. Stumvoll M, van Haeften T, Fritsche A, Gerich J: Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times (Letter). Diabetes Care 24:796–797, 2001[Free Full Text]
   
3. Sabelis LWE, Senden PJ, Zonderland ML, van de Wiel A, Wielders JP, Huisveld IA, van Haeften TW, Mosterd WL: Determinants of insulin sensitivity in chronic heart failure. Eur J Heart Failure 5:759–765, 2003[Medline]
   
4. Bannink EMN, van Doorn J, Stijnen T, Drop SLS, de Muinck Keizer-Schrama SMPF: Free-dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner Syndrome during long-term growth hormone treatment. Clin Endocrinol 65:310–319, 2006[Medline]
   

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				B. A. Maddux, A. Chan, E. A. De Filippis, L. J. Mandarino, and I. D. Goldfine IGF-Binding Protein-1 Levels Are Related to Insulin-Mediated Glucose Disposal and Are a Potential Serum Marker of Insulin Resistance: Response to van Haeften et al. Diabetes Care, June 1, 2007; 30(6): e54 - e54. [Full Text] [PDF]

This Article Extract Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Haeften, T. W. Articles by van Doorn, J. Search for Related Content PubMed PubMed Citation Articles by van Haeften, T. W. Articles by van Doorn, J. Social Bookmarking                What's this?